| Maria Antonieta Rejon, DMD | |
|
71 Route 101a Ste 8, Amherst, NH 03031-2274 | |
| (603) 672-6546 | |
| Not Available |
| Full Name | Maria Antonieta Rejon |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 71 Route 101a Ste 8, Amherst, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750006094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 04779 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Antonieta Rejon, DMD 147 Rangeway Rd Unit 6211, North Billerica, MA 01862-2057 Ph: (754) 204-6371 | Maria Antonieta Rejon, DMD 71 Route 101a Ste 8, Amherst, NH 03031-2274 Ph: (603) 672-6546 |
News Archive
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
InTouch Health, the world's premier provider of acute care telemedicine solutions, has received a new Food and Drug Administration (FDA) 510(k) clearance with expanded indications for use for its range of Remote Presence devices which includes RP-7i®, RP-Lite®, RP-Vantage® and RP-Xpress® as well as VisitOR1® which is sold by and is a registered trademark of Karl Storz.
A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, has demonstrated sustained regression of advanced melanoma in a study of 17 patients by genetically engineering patients' own white blood cells to recognize and attack cancer cells.
The first new projections of future aircraft emissions in 10 years predicts that carbon dioxide and other gases from air traffic will become a significant source of global warming as they double or triple by 2050. The study is in ACS' Environmental Science & Technology, a semi-monthly journal.
› Verified 8 days ago
Malvika Singh, DMD Dentist Medicare: Medicare Enrolled Practice Location: 131 Nh 101a Ste 1, Amherst, NH 03031 Phone: 866-589-4713 | |
Dr. Kenneth George Edwards, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 109 Ponemah Rd, Suite A, Amherst, NH 03031 Phone: 603-673-0782 Fax: 603-673-4747 | |
Bernard W Ang, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1 Limbo Ln, Amherst, NH 03031 Phone: 603-673-5510 | |
Dr. Shivani H Patel, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 71 Route 101a, Amherst, NH 03031 Phone: 603-672-6546 | |
Dr. David L Patten, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1 Limbo Ln, Amherst, NH 03031 Phone: 603-673-5510 | |
Andrew Todd Cheifetz, DMD MED Dentist Medicare: Not Enrolled in Medicare Practice Location: 7 Route 101a, Colonial Park Suite D, Amherst, NH 03031 Phone: 603-673-1000 Fax: 603-673-2422 | |
Dr. Stephen J. Clark, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 102 Ponemah Rd, Amherst, NH 03031 Phone: 603-673-7950 Fax: 603-672-7647 |